FDA Veers From Guidance In Some Supplement Health Claim Decisions – Court
This article was originally published in The Tan Sheet
Executive Summary
FDA made unreasonable demands with disclaimers for proposed qualified health claims for vitamin C and vitamin E to reduce the risk of cancer, according to a court ruling.
You may also be interested in...
Ruling Against Cigarette Warnings Could Impact Other FDA Labeling
A judge’s opinion that requiring graphic images on cigarette packages unconstitutionally compels speech could affect FDA’s qualifications for supplement health claims and its off-label rules. FDA “carries the burden of proving” the required speech is truthful and accurate, says attorney Jonathan Emord.
Ruling Against Cigarette Warnings Could Impact Other FDA Labeling
A judge’s opinion that requiring graphic images on cigarette packages unconstitutionally compels speech could affect FDA’s qualifications for supplement health claims and its off-label rules. FDA “carries the burden of proving” the required speech is truthful and accurate, says attorney Jonathan Emord.
FDA Has Authority To Be Vague On Supplement GMP Standards, Court Rules
FDA can set somewhat vague standards for dietary supplement firms' compliance with some good manufacturing practice regulations, according to a ruling in a complaint challenging the agency's authority to issue GMP requirements.